MYCN and neuroblastoma: In a panel of 32 neuroblastoma cell lines, MYCN or MYC amplification or translocation in adrenergic subtypes was accompanied by upregulated CBS expression, while MYC translocation/activation in mesenchymal cell lines was not (Fig. 5i).